We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
Cap. Flow
+$1.01B
Cap. Flow %
3.28%
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188

Sector Composition

Rank Sector Weight
1 Financials 4.77%
2 Technology 4.11%
3 Healthcare 1.86%
4 Consumer Discretionary 1.76%
5 Industrials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCIC
1776
BCP Investment Corp
BCIC
$86.9M
$55K ﹤0.01%
2,447
-1,180
-33% -$27.5K
TGT icon
1777
CALL
Target
TGT
$62.1B
$55K ﹤0.01%
+3,000
New +$285K
VHI icon
1778
Valhi
VHI
$385M
$55K ﹤0.01%
2,404
JE
1779
DELISTED
Just Energy Group Inc
JE
$55K ﹤0.01%
700
-6
-0.8% -$522
MFG icon
1780
Mizuho Financial
MFG
$129B
$54K ﹤0.01%
17,681
+5,565
+46% +$16.5K
OBE
1781
Obsidian Energy
OBE
$707M
$53K ﹤0.01%
63,067
+21
+0% +$22
SLE icon
1782
Super League Enterprise
SLE
$4.28M
$53K ﹤0.01%
+1
New +$62.1K
KWY
1783
Kingsway Corp
KWY
$249M
$52K ﹤0.01%
23,324
TLC
1784
DELISTED
Taiwan Liposome Company, Ltd. American Depository Shares
TLC
$52K ﹤0.01%
10,000
SIGA icon
1785
SIGA Technologies
SIGA
$223M
$51K ﹤0.01%
10,000
NMR icon
1786
Nomura Holdings
NMR
$28.7B
$50K ﹤0.01%
+11,792
New +$44.8K
OCUL icon
1787
Ocular Therapeutix
OCUL
$1.86B
$50K ﹤0.01%
16,400
+4,500
+38% +$20.1K
NDRA icon
1788
ENDRA Life Sciences
NDRA
$6.17M
$48K ﹤0.01%
1
OVID icon
1789
Ovid Therapeutics
OVID
$435M
$48K ﹤0.01%
14,932
EXPR
1790
DELISTED
Express, Inc.
EXPR
$48K ﹤0.01%
700
CHKP icon
1791
CALL
Check Point Software Technologies
CHKP
$13.3B
$47K ﹤0.01%
+1,000
New +$112K
EYPT icon
1792
EyePoint Inc
EYPT
$1.02B
$47K ﹤0.01%
+2,600
New +$40.3K
MGPI icon
1793
PUT
MGP Ingredients
MGPI
$378M
$47K ﹤0.01%
8,300
PBI icon
1794
Pitney Bowes
PBI
$2.42B
$47K ﹤0.01%
+10,228
New +$41K
AMRN
1795
CALL
Amarin Corp
AMRN
$284M
$46K ﹤0.01%
1,000
+500
+100% +$175K
IAG icon
1796
IAMGOLD
IAG
$8.47B
$46K ﹤0.01%
13,390
+1,000
+8% +$3.6K
VATE icon
1797
INNOVATE Corp
VATE
$114M
$45K ﹤0.01%
1,901
WTI icon
1798
W&T Offshore
WTI
$545M
$45K ﹤0.01%
10,340
ATRS
1799
DELISTED
Antares Pharma, Inc.
ATRS
$45K ﹤0.01%
13,500
PDLI
1800
DELISTED
PDL BioPharma, Inc.
PDLI
$45K ﹤0.01%
20,800
-5,000
-19% -$13.4K

Similar funds

Creative Planning's Q3 2019 Portfolio in Review

As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.

By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.

  • Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
  • Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
  • Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
  • Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
  • Creative Planning opened 164 new positions and closed 188 in Q3 2019.
  • Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.